Top Story

Addition of triptorelin to chemotherapy preserved long-term ovarian function

September 16, 2014

The addition of a luteinizing hormone-releasing analog to chemotherapy preserved long-term ovarian function in premenopausal women with early-stage breast cancer, according to long-term results of the PROMISE-GIM6 trial presented at the Breast Cancer Symposium.

“Moreover, this technique seems to improve the chance of becoming pregnant and does not negatively affect prognosis of patients,” Matteo Lambertini, MD, of the department of medical oncology at U.O. Oncologia Medica 2 in Italy, and colleagues wrote.

figure Meeting News CoverageVideo

Physician-signed letters improved screening rates among women overdue for mammograms

September 15, 2014
SAN FRANCISCO — Carol H. Lee, MD, a diagnostic radiologist at Memorial Sloan Kettering Cancer Center, reacts to study results that showed the addition of…
figure Meeting News CoverageVideo

Combination of cryoablation, ipilimumab active in early-stage breast cancer

September 15, 2014
SAN FRANCSICO — Clifford A. Hudis, MD, FACP, chief of the Breast Cancer Medicine Service at Memorial Sloan Kettering Cancer Center and immediate past president of…
figure Meeting News Coverage

Adjuvant chemotherapy extended OS, DFS in luminal B breast cancer

September 15, 2014
SAN FRANCISCO — Adjuvant chemotherapy significantly prolonged OS and DFS in patients with luminal B breast cancer regardless of HER-2 and PR status, according to…
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
Meeting News Coverage Video
figure

Physician-signed letters improved screening rates among women overdue for mammograms

September 15, 2014
SAN FRANCISCO — Carol H. Lee, MD, a diagnostic radiologist at Memorial Sloan Kettering Cancer Center, reacts to…
More »
CME
figure

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »

Filter By:

Meeting News Coverage

Addition of triptorelin to chemotherapy preserved long-term ovarian function

September 16, 2014
The addition of a luteinizing hormone-releasing analog to chemotherapy preserved long-term ovarian function in premenopausal women with early-stage…
figure Meeting News Coverage Video

Physician-signed letters improved screening rates among women overdue for mammograms

September 15, 2014
SAN FRANCISCO — Carol H. Lee, MD, a diagnostic radiologist at Memorial Sloan Kettering Cancer Center, reacts to study results that showed the…
figure Meeting News Coverage Video

Combination of cryoablation, ipilimumab active in early-stage breast cancer

September 15, 2014
SAN FRANCSICO — Clifford A. Hudis, MD, FACP, chief of the Breast Cancer Medicine Service at Memorial Sloan Kettering Cancer Center and…
figure Meeting News Coverage

Adjuvant chemotherapy extended OS, DFS in luminal B breast cancer

September 15, 2014
SAN FRANCISCO — Adjuvant chemotherapy significantly prolonged OS and DFS in patients with luminal B breast cancer regardless of HER-2 and PR…
Meeting News Coverage

PET/MR improved detection of metastases in breast cancer

September 12, 2014
SAN FRANCISCO — Whole-body PET/MR improved the detection of metastases and reduced the occurrence of false positives compared with PET/CT imaging…
In the Journals

Microbe diversity may influence estrogen metabolism, reduce breast cancer risk in postmenopause

September 12, 2014
Women with greater diversity of gut microbiota appear to have an elevated urinary ratio of hydroxylated estrogen metabolites to parent estrogen…
Meeting News Coverage

Margin status not linked to recurrence, survival in DCIS

September 12, 2014
SAN FRANCISCO — Margin status was not predictive of locoregional recurrence, breast cancer-specific survival or OS among patients with ductal…
figure Meeting News Coverage Video

IBIS-II study demonstrates effectiveness of anastrazole for breast cancer prevention

September 12, 2014
Jack Cuzick, PhD, head of the Cancer Research UK Centre for Cancer Prevention and director of the Wolfson Institute of Preventive Medicine at Queen…
figure Meeting News Coverage Video

Cryoablation plus ipilimumab induced systemic immune responses in early-stage breast cancer

September 11, 2014
SAN FRANCISCO — Heather L. McArthur, MD, MPH, of the Breast Cancer Medicine Service at Memorial Sloan Kettering Cancer Center, reviews data…
Meeting News Coverage

Cryoablation plus ipilimumab induced immune responses in early-stage breast cancer

September 11, 2014
SAN FRANCISCO — The combination of preoperative cryoablation plus ipilimumab conferred higher rates of systemic immune activation compared with…
More Headlines »